Culturing cells in tumor-relevant cystine potentiated GOT1 knockdown in a time- and dose-dependent manner (Fig. 2g and Supplementary Fig. 4a, b), in agreement with our pharmacological studies. This evidence concerns the gene GOT1 and neoplasm.